Finance Watch: Structure Launches Third And Largest US Biopharma IPO Of 2023

First Two, Genelux And Cadrenal, Grossed Just $22m Combined

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.